1. Home
  2. VANI vs FORA Comparison

VANI vs FORA Comparison

Compare VANI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • FORA
  • Stock Information
  • Founded
  • VANI 1998
  • FORA 2014
  • Country
  • VANI United States
  • FORA United States
  • Employees
  • VANI N/A
  • FORA N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FORA Computer Software: Prepackaged Software
  • Sector
  • VANI Health Care
  • FORA Technology
  • Exchange
  • VANI Nasdaq
  • FORA Nasdaq
  • Market Cap
  • VANI 81.2M
  • FORA 69.4M
  • IPO Year
  • VANI 2014
  • FORA N/A
  • Fundamental
  • Price
  • VANI $1.61
  • FORA $2.24
  • Analyst Decision
  • VANI Strong Buy
  • FORA Strong Buy
  • Analyst Count
  • VANI 1
  • FORA 1
  • Target Price
  • VANI $4.00
  • FORA $5.00
  • AVG Volume (30 Days)
  • VANI 484.1K
  • FORA 389.0K
  • Earning Date
  • VANI 11-13-2025
  • FORA 11-11-2025
  • Dividend Yield
  • VANI N/A
  • FORA N/A
  • EPS Growth
  • VANI N/A
  • FORA N/A
  • EPS
  • VANI N/A
  • FORA N/A
  • Revenue
  • VANI N/A
  • FORA $25,031,040.00
  • Revenue This Year
  • VANI N/A
  • FORA $47.82
  • Revenue Next Year
  • VANI N/A
  • FORA $10.11
  • P/E Ratio
  • VANI N/A
  • FORA N/A
  • Revenue Growth
  • VANI N/A
  • FORA 18.59
  • 52 Week Low
  • VANI $0.91
  • FORA $1.64
  • 52 Week High
  • VANI $1.92
  • FORA $4.03
  • Technical
  • Relative Strength Index (RSI)
  • VANI 53.84
  • FORA 50.12
  • Support Level
  • VANI $1.59
  • FORA $2.11
  • Resistance Level
  • VANI $1.81
  • FORA $2.41
  • Average True Range (ATR)
  • VANI 0.15
  • FORA 0.13
  • MACD
  • VANI 0.00
  • FORA -0.00
  • Stochastic Oscillator
  • VANI 49.18
  • FORA 36.11

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: